This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Glimcher, chief executive of Dana-Farber Cancer Institute, said she would step down next month, ending an eight-year run capped by her surprise split with Dana-Farber’s longtime partner, Brigham and Women’s Hospital, and decision to build a cancer center with Beth Israel Deaconess Medical Center. Benjamin L.
Pharmacists can work in a variety of settings, including hospitals, community pharmacies, researchlaboratories, and government agencies. For example, they can become clinical pharmacists and work in hospitals. They can also become researchers, educators, or consultants.
He then had a one-year stint at Merck ResearchLaboratories as Director of Clinical Research for Clinical Hepatology before returning to Bristol Myers-Squibb from 2010-2015. Dr Hughes earned his MD and PhD at Yale School of Medicine.
The Institute of Cancer Research (ICR), along with its hospital partner The Royal Marsden NHS Foundation Trust, has opened a new joint integrated pathology unit (IPU). The IPU will support clinical trial research and will employ new technology to diagnose cancer in a faster and less expensive way.
Take Charleston, South Carolina, for example, where a growing number of medical device and pharmaceutical manufacturers, researchlaboratories and service companies have sprung up or settled in recent years. In mid-sized Charleston, connections and collaborations are a constant.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content